EKF Diagnostics Holdings Monthly Analysis (April 2026)

EKF Diagnostics Hold...

AIM:EKF

£ 0,24

£0,00 (0,00%)

0,24 £

£0,00 (0,00%)

End-of-day quote: 04/10/2026

EKF Diagnostics Holdings Stock Value

Analysts currently see AIM:EKF at the level of Buy.

Buy

EKF Diagnostics Holdings Company Info

EPS Growth 5Y

-12,94%

Market Cap

£0,10 B

Long-Term Debt

£0,00 B

Quarterly earnings

06/17/2026 (E)

Dividend

£0,00

Dividend Yield

0,00%

Founded

1990

Industry

Health Care

Country

United Kingdom

Website

EKF Diagnostics Holdings

ISIN Number

GB0031509804

Website

http://www.ekfdiagnostics.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

£0,35

45.83%

Last Update: 04/11/2026

Analysts: 3

Highest Price Target £0,35

Average Price Target £0,35

Lowest Price Target £0,34

In the last five quarters, EKF Diagnostics Holdings’s Price Target has risen from £0,33 to £0,34 - a 3,03% increase. Three analysts predict that EKF Diagnostics Holdings’s share price will increase in the coming year, reaching £0,35. This would represent an increase of 45,83%.

Top growth stocks in the health care sector (5Y.)

What does EKF Diagnostics Holdings do?

EKF Diagnostics Holdings plc operates primarily in the diagnostic healthcare sector, specializing in the design, development, manufacturing, and sale of diagnostic instruments, reagents, and ancillary products, along with central laboratory reagents. Business Strategy The company's overarching business strategy aims at achieving growth through innovation, expansion into new markets, and the enhancement of existing products and services. With a disciplined approach to resource allocation, the c...

Business Strategy

The company's overarching business strategy aims at achieving growth through innovation, expansion into new markets, and the enhancement of existing products and services. With a disciplined approach to resource allocation, the company focuses on developing proprietary technologies that distinguish its product offerings within the diagnostics sector. A significant aspect of this strategy includes investing in research and development to foster technological advancements that meet evolving market demands.

The company prioritizes building and strengthening relationships with healthcare providers and institutions, which facilitates an understanding of their needs and contributes to the development of effective solutions.

A forward-looking perspective characterizes the company's business strategy, emphasizing adaptation to market trends, technological advancements, and the competitive landscape. Through continuous dialogue with third-party payers and regulatory bodies, the company ensures its product offerings align with the health sector's changing reimbursement environments, mitigating risks associated with third-party dependencies.

Products and Services

The company offers a wide range of products and services focused on enhancing diagnostic capabilities in the healthcare sector. The company’s primary products include diagnostic instruments, reagents for a range of tests, and central laboratory reagents.

The diagnostic instruments produced by the company are characterized by advanced technology and user-friendly designs, enabling accurate health assessments. The reagents, which are crucial to the diagnostic process, enable specific testing that is vital for diagnostics in various medical or health conditions. These products undergo stringent quality control measures to ensure their efficacy, providing healthcare professionals with confidence in the results they produce.

Furthermore, the company's services extend to the servicing and distribution of third-party diagnostic products, expanding its operational portfolio and enabling healthcare providers to seamlessly source a comprehensive array of diagnostic solutions.

Geographical Markets Served

The company operates in key geographical markets, notably the USA, Germany, Russia, and the UK.

Seasonality

Seasonality may influence the company’s operations and financial performance, as demand for diagnostic products and services can vary throughout the year due to factors such as changing disease patterns, healthcare budgets, and seasonal health trends.

Customers

The company serves a diverse customer base including hospitals, clinics, laboratories, and healthcare providers across its operational geographies.

Sales and Marketing

The company's marketing strategy utilizes various channels to reach its target market effectively. This includes digital marketing, engagement with healthcare professionals through conferences, and direct sales initiatives. The company focuses on educating healthcare providers about its products’ unique benefits, contributing to an informed customer base and increased product adoption.

Distribution channels are established to enable seamless access to products, ensuring that diagnostic solutions are readily available to healthcare providers. The company’s distribution framework includes both direct and indirect pathways to ensure efficiency and responsiveness to market needs.

History

EKF Diagnostics Holdings plc was founded in 1990. The company was incorporated in 2002.

New support ticket

Explore

EKF Diagnostics Holdings Stock Value

EKF Diagnostics Holdings Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does EKF Diagnostics Holdings do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

EKF Diagnostics Holdings Stock Value

EKF Diagnostics Holdings Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does EKF Diagnostics Holdings do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.